Restricted accessOtherFirst published online 2000-3
Peripheral Neuroblastic Tumors: Pathologic Classification Based on Recommendations of International Neuroblastoma Pathology Committee (Modification of Shimada Classification)
ShimadaH, AmbrosIM, DehnerLP, HataJI, JoshiVV, RoaldB.Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer1999;86:348–362
2.
ShimadaH, AmbrosIM, DehnerLP, The International Neuroblastoma Pathology Classification (Shimada system). Cancer1999;86:364–372
3.
AmbrosIM, ZellnerA, RoaldB, Role of ploidy, chromosome 1 p and Schwann cells in the maturation of neuroblastoma. New Engl J Med1996;334:1505–1511.
4.
JoshiVV, CantorAB, AltshulerG, Recommendations for modification of terminology of neuroblastic tumors and prognostic significance of Shimada classification. Cancer1992;69:2183–2196.
5.
ShimadaH, ChattenJ, NewtonWA, Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and age-linked classification of neuroblastomas. J Natl Cancer Inst1984;73:405–416.
6.
JoshiVV, SilvermanJF, AltshulerG, Systematization of primary histopathologic and fine-needle aspiration cytologic features and description of unusual histopathologic features of neuroblastic tumors: a report from Pediatric Oncology Group. Hum Pathol1993;24:493–504.
7.
JoshiVV, ChattenJ, SatherHN, ShimadaH.Evaluation of the Shimada classification in advanced neuroblastoma with a special reference to the mitosis-karyorrhexis index: a report from Children's Cancer Study Group. Mod Pathol1991;4:139–147.
8.
CummingsMC, WinterfordCM, WalkerNI. Apoptosis. Am J Surg Pathol1997;21:88–101.
9.
AmbrosIM, KerblR, LadensteinG, Genetic heterogeneity in neuroblastomas. In: International Steering Committee Proceedings of Advances in Neuroblastoma Research. Bath, UK: International Steering Committee1998;16 [Abstract #MS1].
10.
JoshiVV, CantorAB, AltshulerG, Age-linked prognostic categorization based on a new histologic grading system of neuroblastoma. A clinicopathologic study of 211 cases from the Pediatric Oncology Group. Cancer1992;69:2197–2211.
11.
JoshiVV, RaoPV, CantorAB, AltshulerG, ShusterJJ, CastleberryRP. Modified histologic grading of neuroblastomas by replacement of mitotic rate with mitosis karyorrhexis index. A clinicopathologic study of 223 cases from the Pediatric Oncology Group. Cancer1996;77:1582–1588.
12.
NakagawaraA, Arcima-NakagawaraM, ScavardaNJ, Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med1993;328:847–854.
13.
ShimadaH, StramDO, ChattenJ, Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis. J Natl Cancer Inst1995;87:1470–1476.
14.
SoiniY, PaakkoP, LektoV-P.Histopathological evaluation of apoptosis in cancer. Am J Pathol1998;153:1041–1053.
15.
EvanGI, WyllieAH, GilbertCS, Induction of apoptosis in fibroblasts by c-myc protein. Cell1992;69:119–128.
16.
BlackwoodEM, EisenmanRN. Max: a helix-loop-helix zipper protein that forms a sequence specific DNA-binding complex with myc. Science1991;251:1211–1217.
17.
WenzelA, CziephichC, HamannU, SchurmannJ, SchwabM.The N-myc oncoprotein is associated in vivo with phosphoprotein Max (p20/22) in human neuroblastoma cells. EMBO J1991;10:3703–3712.
18.
PotionCS. What is an apoptotic index measuring? [a commentary]. Br J Cancer1996;74:1743–1748.
19.
AnsariB, CoatesPJ, GreensteinBD, HallPA. In situ end-labeling detects DNA strand breaks in apoptosis andother physiological and pathological states. J Pathol1993; 170:1–8.
20.
NegoescuA, LorcimierP, Labat-MoleurF, In situ apoptotic cell labeling by the TUNEL method: improvement and evaluation on cell preparations. J Histochem Cytochem1996;74:1743–1748.
21.
GorczycaW, BednerE, BurfeindP, DarzynkiewiczZ, MelamedMR. Analysis of apoptosis in solid tumors by laser-scanning cytometry. Mod Pathol1998;11:1052–1058.